DLD Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

DLD Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-150,000	Closed	-$2.99M	–	207
2022 Q3	$2.99M	Buy	+150,000	New	+$1.98M	0.23%	82

DLD Asset Management's FMTX Position: Q4 2022 in Review

DLD Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 150,000 shares — an estimated $2.99M sold.

DLD Asset Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $2.99M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

DLD Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
DLD Asset Management sold 150,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $2.99M.
DLD Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
DLD Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.99M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on DLD Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.